SORRENTO THERAPEUTICS INC (SRNE) Stock Cash Flow
NASDAQ:SRNE - Nasdaq - US83587F2020 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -495.50M | -429.14M | -314.41M | -363.01M | -212.53M | |||
| Depreciation Amortization | 12.75M | 12.46M | 11.01M | 10.99M | 9.05M | |||
| Change In Working Capital | 34.58M | -2.79M | 3.80M | 7.25M | 6.00M | |||
| Interest Paid | 1.64M | 1.06M | 3.42M | 12.74M | 1.62M | |||
| Taxes Paid | 29.00K | 1.20M | 0.00 | 10.00K | 10.00K | |||
| Other non cash items | 150.52M | 137.65M | 140.07M | 171.78M | 85.71M | |||
| OPERATING CASH FLOW | -297.66M | -281.82M | -159.54M | -173.00M | -111.77M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.34M | -8.87M | -6.53M | -28.48M | -11.20M | |||
| Other Investing Activity | -14.35M | 88.72M | -33.40M | -9.69M | -10.00M | |||
| INVESTING CASH FLOW | -25.69M | 79.85M | -39.92M | -38.17M | -21.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -52.48M | -35.91M | -186.98M | 22.34M | 279.11M | |||
| Stock Issued/Repurchased | 409.97M | 217.25M | 416.22M | 56.55M | 83.82M | |||
| Other Financing Activity | N/A | N/A | -55.00M | 0.00 | -36.93M | |||
| FINANCING CASH FLOW | 357.50M | 181.33M | 174.24M | 78.89M | 326.00M | |||
| Exchange Rate Effect | -3.20M | 843.00K | 920.00K | -280.00K | -140.00K | |||
| CHANGE IN CASH | 30.95M | -19.80M | -24.30M | -132.56M | 192.89M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -297.66M | -281.82M | -159.54M | -173.00M | -111.77M | |||
| Capital Expenditure | -11.34M | -8.87M | -6.53M | -28.48M | -11.20M | |||
| FREE CASH FLOW | -309.00M | -290.69M | -166.07M | -201.48M | -122.97M | |||
All data in USD